Structural and functional changes in diabetic glomerulopathy

Kidney and Blood Pressure Research

Volumn 19, Issue 5, 1996, Pages 305-315

  Schleicher, E ^a   Kolm, V ^a   Ceol, M ^b   Nerlich, A ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Advanced glucosylation end products; Diabetic nephropathy; Extracellular matrix; Hyperglycemia; Macrophages; Protein kinase C; Transforming growth factor beta

Indexed keywords

COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGEN TYPE 6; PROTEIN KINASE C; PROTEOHEPARAN SULFATE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL INFILTRATION; COLLAGEN SYNTHESIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; GLYCOSYLATION; HUMAN; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; KIDNEY CELL CULTURE; KIDNEY FUNCTION; MACROPHAGE; MESANGIUM; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA;

EID: 0029903601     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000174091     Document Type: Article

References (54)

1. Andersen AR, Christiansen JS, Andersen, IK, Kreiner S, Decken T: Diabetic nephropathy in type I (insulin-dependent) diabetes: An epidemiological study, Diabetologia 1983:26:496-501.
2. Krolcwski AS, Warrant JH, Rand LI, Kahn CR: Epidemiologie approach to the etiology of type I diabetes mellitus and its complications, N Engl J Med 1987:317:1390-1398.
3. Viberti GC, Walker JD, Pinto J: Diabetic nephropathy: in Alberti KOMM, de Fronzo RA, Keen II, Zimmct P (eds): International Textbook of Diabetes mellitus, New York, Wiley & Sons, 1992, vol 2, pp 1267-1328.
4. Seaquist HR, Goetz FC, Rich S, Barbosa J: Familiar clustering of diabetic kidney disease: Evidence for genetic susceptibility to diabetic nephropathy, N Engl J Med 1989:320:1161-1165
5. Pettilt DJ, Saat MF, Bennett PH, Nelson RG, Knowler WC: Familiar predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus, Diabetologia 1990:33:438-443.
6. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes in the development and progression of longterm complications in insulin-dependent diabetes mellitus, N Engl .1 Med 1993:329:977-986.
7. Gall MA, Rossing P, Scott P, Dumsbo P, Vaag A, Bcch K, Dejgaard RD, Lauritzen M, Lauritzen E, I lougaard P, Beck-Nielsen H, Pars ing HH: Prevalence of micro- anil macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dc-pendent) diabetic patients, Diabetologia 1991; 34:655-661.
8. Mogcnscn CE, Andersen NJF: Increased kidney size and glomerular filtration rate in early juvenile diabetes, Diabetes 1973:22:706-712.
9. Kimmelstiel P, Wilson C: Intercapillary lesions in the glomeruli of the kidney, Am J Pathol 1936:12:83-105.
10. Steffes MW. Ostcrby R, Schavers B, Mauer MS: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients, Diabetes 1989:38:1077-1081.
11. Kim Y, Kleppel M, Butkowski R, Matter VI, Wieslander .1, Michael A: Differential expression of basement membrane collagen chains in diabetic nephropathy, Am J Pathol 1991:138: 413-420.
12. Nerlich A, Schleicher E: Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions, Am .1 Pathol 1991:139:889-899.
13. Schleicher ED, Wagner EM, Olgemoller B, Nerlieh AG, Gerbilz KD: Characterization and localization of basement membrane-associated heparan sulfate proteoglycan in human tissues, Lab Invest 1989;61:323-332.
14. Farquhar MG: The glomerular basement membrane: A selective maeromolecular filter; in Hay K (ed): Cell Biology of Extracellular Matrix, New York, Plenum Press, 1981, pp 335-378.
15. Van den Born J, van den Heuvcl PWJ, Bakker MHA, Feerkamp JH, Assmann KJM, Berden JHM: A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats, Kidney Int 1992:41:115-123.
16. Ruoslahti E, Border WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy, Proc Natl Acad Sci USA 1993:90:1814-1818.
17. Ruoslahti F.: Extracellular matrix in the regulation of cellular function; in Burger MM, Sordat B, Zinkemagel RM (eds): Cell-to-Cell Interaction, Basel, Karger, 1990, pp 88-98.
18. D'Amore PA: Modes of FGF release in vivo and in vitro, Cancer Metastasis Rev 1990:9:227-238.
19. Wright fC, Casellot JJ, Diamond RJ, Kamovski YIJ: Regulation of cellular proliferation by heparin and heparan sulfate, in Lane DA, Lindahl U (eds): Heparin, London, Arnold, 1989, pp 295-316.
20. Mohan PS, Kardcr WG, Spiro RG: Occurrence of type VI collagen in extracellular matrix of renal glomeruli and its increase in diabetes, Diabetes 1990;39:31-37.
21. Shimomura H, Spiro RG: Studies on macromo-lecular components of human glomerular basement membrane and alterations in diabetes: Decreased levels of heparan sulfate proteoglycan, Diabetes 1987:36:374-381.
22. Fukui M, Nakamura T, Ebihara 1, Shirato 1, To-mino Y, Koide H: F.CM gene expression and its modulation by insulin in diabetic rats, Diabetes 1992:41:1520-1547.
23. Nerlieh A, Schleicher ED, Wicst I, Specks U, Tirnpl R: Immunohistochemical localization of collagen VI in diabetic glomeruli, Kidney Int 1994:45:1648-1656.
24. Ceol M, Nerlieh A, Baggio B, Anglani F, Sauer U, Schleicher E, Gambaro G: Increased glo-mcrularui (IV) collagen expression ami deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment, Lab Invest 1996:74:484-495.
25. Vernier RL, Steffcs ME, Sissons-Ross S, Maucr VI: I leparan sulfate proteoglycan in the glomerular basement membrane in type I diabetes mcllitus, Kidney Int 1992;41:1070-1080.
26. Tamsma JT, van den Bom J, Bruijn JA, Assmann KJM, Weening JJ, Berdcn JHM, Wieslan-der .1, Schramcr E, Heermans J, Veerkamp Jll, Lcmkes HHPJ, van der Woude J: Expression of glomerular extracellular matrix components in human diabetic nephropathy: Decrease of heparan sulfate in the glomerular basement membrane, Diabetologia 1994:37:313-320.
27. Olgemoller B, Schwaabe S, Gcrbitz KD, Schleicher ED: Elevated glucose decreases the content of a basement membrane-associated proteoglycan in proliferating mesangial cells, Diabetologia 1992:35:183-186.
28. Alpers C E, Hudkins KL, Gown AM, Johnson RJ: Enhanced expression of‘muscle-specific’ actin in glomerulonephritis, Kidney Int 1992; 41:1134-1142.
29. Izumino K, Futamura A, Nakagawa Y, Takata M, Inoue IL lida II: Macrophage in glomerular lesion of non-insulin dependent diabetic (NIDDM) rats, J Am Soc Nephrol 1994:4:43.
30. Flocge J, Eng E, Lindner V, Alpers CE, Young BA, Rcidy MA, Johnson RJ: Rat glomerular mesangial cells synthesize basic fibroblast growth factor, J Clin Invest 1992:90:2362-2369.
31. Yamamota T, Nakamura T, Noble N A, Ruoslahti E, Border WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy, Proc Natl Acad Sci USA 1993:90:1814-1818.
32. Flyvbjerg A, Nielsen B, Skjaerbaek C, Frystyk J, Gronbcck H, Orskov H: Roles of growth factor in diabetic kidney disease: in Mogensen CE (ed): The Kidney and Hypertension in Diabetes mcllitus, Dordrecht, Kluwer, 1994, pp 233-243.
33. Nakamura T, Fukui M, Ebihara J, Osada S, Na-gauka I, Tomino Y, Koide II: mRNA-expression of growth factors in glomeruli from diabetic rats, Diabetes 1993;42:450-456.
34. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease: The case for transforming growth factor as a key mediator, Diabetes 1995:44:1139-1146.
35. Ayo SH, Radnik RA, Glass WF, Garoni JA, Rampt ER, Appling DR, Kreisberg JI: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium, Am J Physiol 1990:260:F185-F191.
36. Danne T, Spiro MJ, Spiro RG: Effect of high glucose on type IV collagen production by cultured glomerular epithelial, endothelial, and mesangial cells, Diabetes 1993:42:170-177.
37. Wolf G, Sharma K, Chen Y, Ericksen M, Zvadeh FN: High glucose-induced proliferation in mesangial cells is reserved by autocrine TGF-L Kidney Int 1992:42:647-656.
38. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by activation of transforming growth factor β, J Clin Invest 1994:93: 536-542.
39. Ayo SH, Radnik R, Garoni JA, Troyer DA, Kreisberg JA: High glucose increases diacylglycérol mass and activates protein kinase C in mesangial cells, Am J Physiol 1991:261: F571-F577.
40. Guzman NJ, Crews FT: Regulation of inositol transport by glucose and protein kinase C in mesangial cells, Kidney Int 1992:42:33-40.
41. Larkins RG, Dunlop ME: The link between hy-perglycaemia and diabetic nephropathy, Diabc-tologia 1992:35:499-504.
42. Craven PA, DcRubertis FR: Protein kinase C is activated in glomeruli from streptozotocin diabetic rats: Possible mediation by glucose, J Clin Invest 1989:83:1667-1675.
43. Inoguchi T, Battan R, I landler E, Sportsman JR, Heath W, King GL: Preferential elevation of protein kinase C isoform and diacylglycerol levels in the aorta in hearts of diabetic rats: Differential reversibility loglycemic control by islet cell transplantation, Proc Natl Acad Sci USA 1992;89:11059-11063.
44. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kent TS, Balias I.M, Heath WF, Stratum LE, Fccner EEP, King GL: Amelioration of vascular dysfunctions in diabetic rats by an oral PKCβ inhibitor, Science 1996:272:728-730.
45. Brownlee M, Ceratni A, Vlassara 11: Advanced glucosylation end products in tissue and the biochemical basis of diabetic complications, N Engl J Med 1988:318:1315-1321.
46. Vogt BW, Schleicher ED, Wieland OH: e-Ami-nolysine bound glucose in human tissues obtained at autopsy: Increase in diabetes mcllitus, Diabetes 1982:31:1123-1127.
47. Ledl F, Schleicher E: New aspects of the Mail-lard reaction in foods and in the human body, AngcwChem Int Ed 1990;29:565-594.
48. Vlassara H, Brownlee M, Ccrami A: Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors, J Exp Med 1986:164:1301-1309.
49. Doi T, Vlassara LI, Kirstein M, Yamada Y, Striker GE, Striker LJ: Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glyeosyla-tion end products in mediated via platelet-derived growth factor, Proc Natl Acad Sci USA 1992:89:2873-2877.
50. Silbinger S, Crowley S, Shan Z, Brownlee M, Satriano J, Schlondorff D: Nonenzymatic gly-cation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge, Kidney Int 1993;43:853-864.
51. Greene D: The pathogenesis and its prevention of diabetic neuropathy and nephropathy, Metabolism 1988;37(suppl 1):25-29.
52. McCalcb ML, Me Kean ML, llohman TC, Laver N, Robinson WG: Intervention with aldose reductase inhibitor, tolrcstat, in renal and retinal lesions of streptozotocin diabetic rats, Diabetologia 1991:34:659-701.
53. Calgami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix synthesis through induction of transforming growth factor β expression in rat glomerular mesangial cells, J Clin Invest 1994:93:2431-2437.
54. Kolm V, Sauer U, Olgemoller B, Schleicher ED: High glucose-induced TGF-β1 regulates mesangial production of heparan sulfate proteoglycan, Am J Physiol 1996:39:F812-F821.